Phase 2a Evaluation of Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Patients With Primary Sclerosing Cholangitis (PSC)
Clinical trial NCT04480840 · COMPLETED
Trial details
- NCT number
- NCT04480840
- Sponsor
- Pliant Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-27
- Primary completion
- 2024-02-26
- Enrollment
- 121
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.